A8

A8 is a dynamic venture builder dedicated to commercializing research-based innovations. Focusing on innovations originating from the European Research Council (ERC), the European Innovations Council (EIC), and the European Institute of Innovation & Technology (EIT), A8 is committed to fostering groundbreaking advancements. The company is actively developing a diverse portfolio of startups featuring disruptive technologies, and is also developing and operating its flagship Genomics Software Suite (GSS).

A8 is involved in several key initiatives, including Ventures Thrive, an EIC-backed investment program supporting 32 deep-tech startups from Widening countries. As a recognized EIC partner and beneficiary in EIC Transition projects, A8 plays a vital role in projects like eBeam4Therapy, BioPure, AQLAS, and XXXXX, pioneering innovations in healthcare, biomedicine, atomic quantum engineering, and solid-state cooling. The primary address of A8 is in Valletta, MT.

At A8, the mission is to empower innovators by providing them with the freedom to focus on their core activities. A8 manages technology and business development, along with partner and resource acquisition. We invite the manager of A8 to enhance your company’s profile by creating a customized and exclusive company showcase and product listing on our platform.